Yangzhe Wu Selected Research

Yangzhe Wu Research Topics

13	Neoplasms (Cancer) 11/2023 - 03/2009
1	Tuberculosis (Tuberculoses) 11/2023
1	Fever (Fevers) 10/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Diabetic Foot 01/2021
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Communicable Diseases (Infectious Diseases) 05/2019
1	Lymphatic Metastasis 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Cholangiocarcinoma 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019
1	Breast Neoplasms (Breast Cancer) 10/2015
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2013
2	CytokinesIBA 11/2023 - 01/2020
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2013 - 01/2012
1	Complement System Proteins (Complement)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2020
1	ButyrophilinsIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	SeleniumIBA 11/2019
1	TubulinIBA 11/2019
1	C-Reactive ProteinIBA 05/2019
1	PerforinIBA 01/2019
1	Biocompatible Materials (Biomaterials)IBA 01/2019
1	AlkaloidsIBA 01/2019
1	lonidamineIBA 01/2019
1	ChitosanIBA 01/2019
1	MatrinesIBA 01/2019
1	HexokinaseIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 10/2015
1	Vehicle Emissions (Emissions, Vehicle)IBA 01/2013
1	CarcinogensIBA 03/2009

6	Immunotherapy 11/2023 - 01/2019
4	Therapeutics 01/2022 - 01/2021
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 01/2019
1	Radiotherapy 01/2019
1	Liver Transplantation 01/2019
1	Drug Therapy (Chemotherapy) 01/2019